Literature DB >> 9298538

Cloning, expression and pharmacology of a truncated splice variant of the human 5-HT7 receptor (h5-HT7b).

J R Jasper1, A Kosaka, Z P To, D J Chang, R M Eglen.   

Abstract

1. The rat 5-hydroxytryptamine (5-HT)7 receptor displays two splice variations, a long form, and a truncated splice isoform, arising from the introduction of a stop codon near the carboxy-terminus. The human-5HT7 receptor gene contains at least two introns and encodes a 445 amino acid 5-HT receptor. 2. A truncated splice variation in the human 5-HT7 receptor was isolated from a human placental cDNA library. In accordance with current NC-IUPHAR nomenclature guidelines, it is suggested that this receptor be donated as the h5-HT7b receptor and the long form of the receptor as h5-HT7a. 3. The h5-HT7b receptor was stably expressed in HEK 293 cells and ligand affinities were determined by displacement of [3H]-5-carboxyamidotryptamine (5-CT; Kd = 0.28 +/- 0.6 nM, Bmax = 7.3 +/- 17 pmol mg-1 protein). The rank order of affinities (pKi) for a series of ligands was: 5-carboxamidotryptamine (5-CT, 9.65) > 5-hydroxytryptamine (5-HT, 9.41) > methiothepin (8.87) > mesulergine (7.87) > 8-hydroxy-2 (di-n-propylamino)tetralin (8-OH-DPAT, 6.85) > ketanserin (6.44). 4. The h5-HT7b receptor coupled positively to adenylyl cyclase in HEK 293 cells. This response was elicited by a number of agonists with the following order of potency (pEC50): 5-CT (8.7 +/- 0.11) > 5-MeOT (5-methoxytryptamine; 8.1 +/- 0.20) > 5-HT (7.5 +/- 0.13) tryptamine (5.6 +/- 0.36) > 8-OH-DPAT (5.3 +/- 0.28) > 5-methoxytryptamine (5.0 +/- 0.06). This rank order was comparable to that observed in the radioligand binding studies. 5. In a similar fashion to that described for the 5-HT7a receptor, PCR studies suggested that the 5-HT7b receptor mRNA is found in great abundance throughout the brain, in the small intestine and aorta. 6. It is concluded that the h5-HT7 receptor, like the rat receptor, exists as splice variants exhibiting similar pharmacology, signal transduction and distribution. It is thus likely that there exists a complex physiological role for alternate splicing products of the 5-HT7 receptor gene.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9298538      PMCID: PMC1564895          DOI: 10.1038/sj.bjp.0701336

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  35 in total

1.  [(3)H]-SB-269970--A selective antagonist radioligand for 5-HT(7) receptors.

Authors:  D R Thomas; P J Atkinson; M Ho; S M Bromidge; P J Lovell; A J Villani; J J Hagan; D N Middlemiss; G W Price
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

2.  High-affinity interactions of ligands at recombinant guinea pig 5HT7 receptors.

Authors:  R E Wilcox; J E Ragan; R S Pearlman; M Y Brusniak; R M Eglen; D W Bonhaus; T E Tenner; J D Miller
Journal:  J Comput Aided Mol Des       Date:  2001-10       Impact factor: 3.686

3.  The human 5-HT7 serotonin receptor splice variants: constitutive activity and inverse agonist effects.

Authors:  Kurt A Krobert; Finn Olav Levy
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

4.  Smooth muscle 5-HT2A receptors mediating contraction of porcine isolated proximal stomach strips.

Authors:  P Janssen; N H Prins; A L Meulemans; R A Lefebvre
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

5.  Functional expression of the serotonin 5-HT7 receptor in human glioblastoma cell lines.

Authors:  Cécile Mahé; Michel Bernhard; Ionel Bobirnac; Corinna Keser; Erika Loetscher; Dominik Feuerbach; Kumlesh K Dev; Philippe Schoeffter
Journal:  Br J Pharmacol       Date:  2004-08-31       Impact factor: 8.739

6.  Genome-wide association study of theta band event-related oscillations identifies serotonin receptor gene HTR7 influencing risk of alcohol dependence.

Authors:  Mark Zlojutro; Niklas Manz; Madhavi Rangaswamy; Xiaoling Xuei; Leah Flury-Wetherill; Daniel Koller; Laura J Bierut; Alison Goate; Victor Hesselbrock; Samuel Kuperman; John Nurnberger; John P Rice; Marc A Schuckit; Tatiana Foroud; Howard J Edenberg; Bernice Porjesz; Laura Almasy
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-11-02       Impact factor: 3.568

7.  Differential profile of typical, atypical and third generation antipsychotics at human 5-HT7a receptors coupled to adenylyl cyclase: detection of agonist and inverse agonist properties.

Authors:  Isabelle Rauly-Lestienne; Elisa Boutet-Robinet; Marie-Christine Ailhaud; Adrian Newman-Tancredi; Didier Cussac
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-09-05       Impact factor: 3.000

Review 8.  Molecular underpinnings of ventral surface chemoreceptor function: focus on KCNQ channels.

Authors:  Daniel K Mulkey; Virginia E Hawkins; Joanna M Hawryluk; Ana C Takakura; Thiago S Moreira; Anastasios V Tzingounis
Journal:  J Physiol       Date:  2015-02-19       Impact factor: 5.182

9.  Isolation and characterization of new exon 11-associated N-terminal splice variants of the human mu opioid receptor gene.

Authors:  Jin Xu; Mingming Xu; Yasmin L Hurd; Gavril W Pasternak; Ying-Xian Pan
Journal:  J Neurochem       Date:  2008-12-10       Impact factor: 5.372

10.  Autoradiographic distribution of 5-HT7 receptors in the human brain using [3H]mesulergine: comparison to other mammalian species.

Authors:  Francisco J Martín-Cora; Angel Pazos
Journal:  Br J Pharmacol       Date:  2003-12-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.